DarwinHealth™ is a precision-focused cancer medicine company that has developed, owns, and utilizes proprietary algorithms and methodologies to match virtually every individual cancer patient – at every stage of their disease – with those drugs and drug combinations that are optimally suited to produce successful treatment outcomes.
Conversely, these same methodologies can be used to prioritize drugs and drug combinations of unknown potential against the vast majority of human malignancies. As a result, they are invaluable for helping pharmaceutical companies optimize their developmental compound pipelines. In addition, they provide DarwinHealth™ with an edge drug discovery platform for prioritizing highly effective and yet under-valued compounds for its own acquisition, in-licensing, and/or clinical development. MORE>
Media
Watch and read about DarwinHealth™ in the global media
Leadership Team
PROFESSOR ANDREA CALIFANO, Dr.
Co-founder and Chief Scientific Advisor
GIDEON BOSKER, MD
Co-founder and Chief Executive Officer
MARIANO ALVAREZ, PhD
Chief Scientific Officer
YAO SHEN, PhD
Director of Systems Pharmacology Senior Data Scientist
STUART ANDREWS, PhD
Chief Data Sciences Technology Officer (CDSTO)
XIAOYUN SUN, PhD
Senior Computational Biologist
MARIANA BABOR, PhD
Senior Manager, Computational Biology
Team Leader, Computational Immunobiology/Immuno-Oncology
PASQUALE LAISE, PhD
Director of Single Cells Systems Biology and
Senior Scientist Computational and Experimental Biology